DEF 14A Filing

Company

AIM ImmunoTech Inc.

Filed

August 3, 2018

Period of Report

August 3, 2018

Accession Number

0001493152-18-010893

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →